Incremental innovation consists of introducing in Brazilian market existing assets in the world or promoting incremental improves, such as new associations, formulations, therapeutic indications, and application of different technologies in existing assets, thus bringing innovative proposals to understand the needs of doctors and patients.
The NILE – Nanotechnology Innovation Laboratory Enterprise laboratory, inaugurated in partnership with the company Ferring Pharmaceuticals, has the latest equipment to apply nanotechnology to prototypes that can later be transferred to industrial scale.
For the incremental innovation platform called Innovatech®, the main mission is the application of new technologies in known molecules to solve problems related to stability, solubility, bioavailability, flavor, low action time and route of administration, allowing the development of pharmaceutical products respond to unmet medical needs.
SUPPORT
